Minot Wealth Management LLC Gilead Sciences, Inc. Transaction History

Minot Wealth Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$57.72 - $65.01 $226,724 - $255,359	-3,928 Closed	0 $0
Q1 2022 Apr 14, 2022	BUY	$57.92 - $72.58 $55,197 - $69,168	953 Added 32.03%	3,928 $234,000
Q4 2021 Jan 20, 2022	SELL	$64.88 - $73.64 $44,572 - $50,590	-687 Reduced 18.76%	2,975 $216,000
Q3 2021 Oct 25, 2021	BUY	$67.69 - $73.03 $247,880 - $267,435	3,662 New	3,662 $256,000
Q2 2021 Jul 19, 2021	SELL	$63.47 - $69.35 $805,815 - $880,467	-12,696 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$60.0 - $68.46 $761,760 - $869,168	12,696 New	12,696 $821,000
Q4 2020 Jan 28, 2021	SELL	$56.65 - $64.55 $1.99 Million - $2.27 Million	-35,210 Closed	0 $0
Q3 2020 Oct 13, 2020	BUY	$62.1 - $78.08 $217,225 - $273,123	3,498 Added 11.03%	35,210 $2.23 Million
Q2 2020 Jul 14, 2020	BUY	$72.34 - $84.0 $830,246 - $964,068	11,477 Added 56.72%	31,712 $2.44 Million
Q1 2020 Apr 27, 2020	BUY	$62.63 - $80.22 $1.27 Million - $1.62 Million	20,235 New	20,235 $1.51 Million

1,926

993M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Minot Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Minot Wealth Management LLC with notifications on news.